The study authors are careful to note that their findings do not provide a definitive breakdown of how much each of these factors—awareness, access, or threshold shifts—contributes to the trend. However, they argue that the data should caution against interpreting rising diagnosis rates as a simple one-to-one reflection of rising biological occurrence.
"Our findings help us better understand why ADHD and autism diagnoses have increased so markedly in recent years," said Oleguer Plana-Ripoll, a researcher at ISGlobal and Aarhus University and the senior author of the study. "They do not show that these conditions are being overdiagnosed or that they have become less severe. Rather, they indicate that the population receiving these diagnoses has changed over time, and this needs to be taken into account when interpreting current trends."
Plana-Ripoll also noted that while the Danish data is exceptionally high-quality, further research in other countries is necessary to see if these patterns hold true in different healthcare systems and cultural contexts.
What the findings could mean
The implications of this study extend far beyond the walls of research laboratories. They have the potential to reshape how we plan for the future of healthcare, education, and social services.
If the population of people with ADHD and ASD now more closely resembles the general public, the "average" needs of this population may also be changing. This is particularly relevant for the planning of support services. If a larger proportion of diagnosed individuals have "milder" symptoms or fewer co-occurring socioeconomic challenges, the types of interventions required may need to be broader and more varied than the intensive services designed for the more severely affected populations of the past.
The study also raises important questions about how we measure "success" in treatment and support. In recent years, some reports have suggested that long-term outcomes for people with ADHD and ASD are improving. However, the new findings suggest a more complex reality. If the modern diagnosed population includes more people who started with fewer "risk factors" (such as healthy birth weights and higher socioeconomic stability), their "better" outcomes might be a reflection of their baseline characteristics rather than an improvement in the effectiveness of treatments or the prognosis of the conditions themselves.
This "dilution effect" means that researchers must be more careful when comparing current patient outcomes to those from previous decades. Without accounting for the shifting demographics of the diagnosed population, scientists risk drawing incorrect conclusions about how well current therapies are working.
Ultimately, the research highlights a society in transition. As the boundaries between "typical" and "atypical" development continue to blur in the clinical world, the challenge for the next decade will be ensuring that diagnostic labels lead to meaningful support for a more diverse and representative population of children and adolescents. The narrowing gap between those with a diagnosis and the general population suggests that neurodivergence is increasingly being recognized as a common part of the human experience, rather than a rare condition confined to specific high-risk groups.
